Wuxi Apptec Sustainability Profile
Wuxi Apptec, a leading global contract research, development, and manufacturing organisation (CRDMO), is headquartered in Wuxi, China. Founded in 2000, the company has expanded its operational footprint across North America, Europe, and Asia, establishing itself as a key player in the biopharmaceutical industry. Wuxi Apptec offers a comprehensive suite of services, including drug discovery, development, and manufacturing, which are distinguished by their innovative technologies and commitment to quality. The company has achieved significant milestones, such as the establishment of multiple state-of-the-art facilities and a robust portfolio of partnerships with major pharmaceutical firms. Recognised for its market leadership, Wuxi Apptec continues to drive advancements in the life sciences sector, providing essential support to clients in bringing new therapies to market efficiently and effectively.
DitchCarbon Score
How does Wuxi Apptec's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Wuxi Apptec's score of 55 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Wuxi Apptec's reported carbon emissions
In 2024, WuXi AppTec reported total greenhouse gas emissions of approximately 2,287,403,590 kg CO2e, comprising 66,471,640 kg CO2e from Scope 1, 531,112,110 kg CO2e from Scope 2, and 1,689,819,840 kg CO2e from Scope 3 emissions. The total emissions for 2023 were about 680,373,980 kg CO2e, with Scope 1 emissions at 68,853,620 kg CO2e, Scope 2 at 467,798,350 kg CO2e, and Scope 3 at 143,722,000 kg CO2e. WuXi AppTec has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 GHG emissions by 42% by 2030 from a 2024 baseline. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions from purchased goods and services and fuel- and energy-related activities within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support the global effort to limit warming to 1.5°C. The company is committed to reducing its GHG emissions intensity by 25% by 2030, further demonstrating its dedication to combating climate change. WuXi AppTec's emissions data and reduction targets reflect its proactive approach to sustainability within the pharmaceuticals, biotechnology, and life sciences sector, headquartered in China.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 6,643,770 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 144,938,320 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is Wuxi Apptec's Industry?
How Carbon Intensive is Wuxi Apptec's Location?
Wuxi Apptec's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Wuxi Apptec has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Syneos Health
Frequently Asked Questions
Common questions about Wuxi Apptec's sustainability data and climate commitments